Canada markets open in 1 hour 28 minutes

Quest PharmaTech Inc. (QPT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.03000.0000 (0.00%)
At close: 12:18PM EDT
Full screen
Previous Close0.0300
Open0.0300
Bid0.0300 x 0
Ask0.0350 x 0
Day's Range0.0300 - 0.0300
52 Week Range0.0200 - 0.1100
Volume1,000
Avg. Volume25,140
Market Cap5.074M
Beta (5Y Monthly)0.29
PE Ratio (TTM)N/A
EPS (TTM)-0.1200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 21, 2005
1y Target EstN/A
  • CNW Group

    Quest Receives Cash Dividend Payment from OncoQuest

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced that it has received a cash dividend payment from OncoQuest Inc. ("OncoQuest", one of Quest's investee companies) of approximately Cdn $685,000. Quest has a 42.5% ownership interest in OncoQuest. The dividend income will be used by Quest for general corporate purposes.

  • CNW Group

    Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced that it has received information that the Phase III clinical trial of oregovomab for the treatment of Ovarian Cancer, sponsored by CanariaBio Inc ("CAB"), has received recommendations from the Data Safety Monitoring Board (DSMB), an independent committee appointed by CAB to advise

  • CNW Group

    Quest PharmaTech Provides Corporate Update

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") wishes to provide an update to its June 2 and June 6, 2023 news releases announcing the entry into of a non-binding agreement in principle (the "Agreement in Principle") with OQP Bio Inc. ("OQP Bio") for the potential monetization of bonds held by Quest in OQP Bio.